Clinical Trial Update: A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS [Phase 2]

View source ↗

Summary

A Phase IIa clinical trial is evaluating intravenous infusion of human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) for safety and efficacy in acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• hUC-MSCs (human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Shenzhen Wingor Biotechnology Co., Ltd. | Conditions: Acute Ischemic Stroke AIS | Phase 2 | Status: RECRUITING